Local News

• Wyeth's major depressive disorder treatment Pristiq now available in U.S. pharmacies  Wyeth Pharmaceuticals announced that PRISTIQ(TM), a new serotonin-norepinephrine reuptake inhibitor approved to treat adult patients with major depressive disorder, is now available in U.S. retail pharmacies nationwide. The recommended dose of PRISTIQ is 50 milligrams (mg) once daily.
  Wyeth May 15, 2008  
• FDA approves AstraZeneca’s Seroquel for maintenance treatment in bipolar disorder  AstraZeneca announced that the U.S. Food and Drug Administration has approved SEROQUEL(R) (quetiapine fumarate) for the maintenance treatment of patients with bipolar I disorder, as adjunct to lithium or divalproex.
  AstraZeneca May 14, 2008  
• DuPont and Genencor create world-leading cellulosic ethanol company  DuPont and Genencor announced an agreement to form DuPont Danisco Cellulosic Ethanol, a 50/50 global joint venture to develop and commercialize the leading, low-cost technology solution for the production of cellulosic ethanol to address a $75 billion global market opportunity.
  Genencor May 14, 2008  
• F.D.A. chief writes Congress for money  After being pummeled for weeks on Capitol Hill over the president's budget, Food and Drug Commissioner Andrew C. von Eschenbach has written Congress that the agency needs an immediate infusion of $275 million to ensure that imported foods, drugs and medical devices are safe.
  The New York Times May 14, 2008  Gardiner Harris
• Lilly employees from nearly 50 nations participate in first-ever Global Day of Service  Thousands of Eli Lilly and Company employees in nearly 50 nations are rolling up their sleeves to help address local community needs in celebration of Lilly's first-ever Global Day of Service, possibly the largest corporate volunteer initiative to ever take place on one day.
  Eli Lilly and Company May 14, 2008  
• BioLife Solutions announces FDA Master File Acceptance for CryoStor™  BioLife Solutions, a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that its Master File for CryoStor cryopreservation media has been accepted by the US Food and Drug Administration (FDA).
  BioLife Solutions Inc. May 14, 2008  
• Merck wins appeal in VIOXX(R) case  Merck & Co. said a Texas appellate court overturned the April 2006 verdict of a state court jury in Starr County, Texas, in the VIOXX product liability case Garza v. Merck. The Texas Fourth Court of Appeals reversed the jury's verdict and rendered a judgment in favor of Merck.
  Merck & Co., Inc. May 14, 2008  
• Pfizer names Garry Nicholson to head new Oncology Business Unit  Pfizer named Garry A. Nicholson as Senior Vice President, General Manager of the company's newly created Oncology Business Unit, reporting to Ian Read, President of Pfizer Worldwide Pharmaceutical Operations.
  Pfizer Inc. May 14, 2008  
• Invitrogen launches new animal origin free substrate for stem cells  Invitrogen announced the launch of CELLstart(TM), the first fully defined, completely animal origin free substrate in the marketplace for the attachment and expansion of embryonic, mesenchymal and neural stem cells.
  Invitrogen Corporation May 13, 2008  
• State-of-the-art cobalt chromium bare metal stent now available in Europe  Cordis announced the availability of the PRESILLION(TM) Cobalt Chromium (CoCr) Coronary Stent in Europe. A bare metal stent, the PRESILLION(TM) stent provides flexibility that delivers the stent through the arteries, and conformability and scaffolding that adapts to the vessel when deployed.
  Johnson & Johnson May 13, 2008  

   (next 10 articles)